Weifeng Tang Selected Research

Ghrelin Receptors

11/2007	Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.
10/2007	Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weifeng Tang Research Topics

Disease

31	Neoplasms (Cancer) 11/2022 - 01/2013
13	Type 2 Diabetes Mellitus (MODY) 10/2022 - 06/2017
12	Asthma (Bronchial Asthma) 09/2022 - 01/2020
11	Esophageal Neoplasms (Esophageal Cancer) 11/2022 - 05/2012
9	Carcinogenesis 11/2022 - 01/2015
9	Inflammation (Inflammations) 04/2022 - 01/2015
7	Body Weight (Weight, Body) 10/2022 - 10/2007
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
6	Adenocarcinoma 12/2017 - 04/2014
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
5	Respiratory Hypersensitivity 01/2022 - 02/2021
5	Esophageal Squamous Cell Carcinoma 08/2021 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 07/2019
2	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 11/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 12/2021 - 01/2020
2	Obesity 01/2021 - 10/2007
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2015 - 01/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2013 - 01/2013
1	Liver Neoplasms (Liver Cancer) 11/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Metaplasia 09/2022
1	Idiopathic Pulmonary Fibrosis 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Thymoma (Thymic Carcinoma) 12/2021
1	Myasthenia Gravis 12/2021
1	Eosinophilia 12/2021

Drug/Important Bio-Agent (IBA)

12	dapagliflozinIBA 10/2022 - 01/2018
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2007
9	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2013
7	CytokinesIBA 09/2022 - 01/2015
7	OvalbuminIBA 01/2022 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2016
6	SodiumIBA 01/2022 - 01/2019
6	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2020 - 01/2015
6	ORALIT (ORS)IBA 12/2019 - 01/2015
5	PPAR gammaIBA 09/2020 - 01/2015
5	InterleukinsIBA 01/2020 - 10/2013
4	CTLA-4 AntigenIBA 07/2019 - 01/2014
4	LeptinIBA 01/2019 - 12/2017
3	CollagenIBA 04/2022 - 01/2020
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2019
3	Interleukin-13IBA 12/2021 - 01/2020
3	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2020
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 12/2019
3	Gefitinib (Iressa)FDA Link 01/2021 - 01/2018
3	SymportersIBA 01/2021 - 01/2019
3	Insulin (Novolin)FDA Link 01/2021 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
3	cediranib (AZD2171)IBA 01/2018 - 01/2017
2	Phosphotransferases (Kinase)IBA 04/2022 - 02/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2020
2	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 02/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 12/2021 - 11/2021
2	Interleukin-4 (Interleukin 4)IBA 08/2021 - 01/2020
2	ChemokinesIBA 07/2021 - 01/2020
2	Biological ProductsIBA 05/2021 - 12/2017
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Aryldialkylphosphatase (Paraoxonase)IBA 09/2020 - 11/2017
2	Drug CombinationsIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 12/2017 - 02/2016
2	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2017 - 02/2014
2	Cyclin D1IBA 01/2016 - 01/2015
2	AZD 1480IBA 02/2015 - 01/2013
2	Ghrelin ReceptorsIBA 11/2007 - 10/2007
1	IsoflavonesIBA 09/2022
1	Estrogens (Estrogen)FDA Link 09/2022
1	TEA Domain Transcription FactorsIBA 04/2022
1	bisphenol FIBA 04/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2022
1	bis(4-hydroxyphenyl)sulfoneIBA 04/2022
1	CopperIBA 01/2022
1	baohuoside IIBA 01/2022
1	saxagliptin FDA Link 01/2022
1	5-hydroxysaxagliptinIBA 01/2022
1	anifrolumabIBA 01/2022
1	AntibodiesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022

Therapy/Procedure

3	Therapeutics 09/2022 - 01/2021
2	Acupuncture Therapy 02/2021 - 01/2021
1	Glycemic Control 10/2022
1	Catgut 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022
1	Anesthesia 12/2021
1	Thymectomy 12/2021